Search research articles
Contact Us
Filters
Showing results (311-320 of 330) with videos related to
Page
of 33
Sort By:
Nature Medicine
|
October 16, 2007
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray, Markus Britschgi, Charles Herbert, et al.
JAMA
|
January 20, 2011
Use of florbetapir-PET for imaging beta-amyloid pathology
Christopher M Clark, Julie A Schneider, Barry J Bedell, et al.
Journal of Neuropathology and Experimental Neurology
|
December 17, 2013
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates
Brittany N Dugger, Christopher M Clark, Geidy Serrano, et al.
Journal of Neuropathology and Experimental Neurology
|
June 15, 2016
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
Jessica R Filon, Anthony J Intorcia, Lucia I Sue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2023
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium
Lavanya Jain, Maria Khrestian, Shane Formica, et al.
Plos One
|
April 23, 2020
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia
Thomas G Beach, Charles H Adler, Nan Zhang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
August 11, 2017
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
Stephen Salloway, Jose E Gamez, Upinder Singh, et al.
Brain : a Journal of Neurology
|
April 27, 2021
Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation
Clemens Neudorfer, Gavin J B Elias, Martin Jakobs, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2018
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation
Jeannie-Marie S Leoutsakos, Haijuan Yan, William S Anderson, et al.
JAMA Neurology
|
January 27, 2015
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density
Craig Curtis, Jose E Gamez, Upinder Singh, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 330) with videos related to
Sort By:
Page
of 33
Nature Medicine
|
October 16, 2007
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray, Markus Britschgi, Charles Herbert, et al.
JAMA
|
January 20, 2011
Use of florbetapir-PET for imaging beta-amyloid pathology
Christopher M Clark, Julie A Schneider, Barry J Bedell, et al.
Journal of Neuropathology and Experimental Neurology
|
December 17, 2013
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates
Brittany N Dugger, Christopher M Clark, Geidy Serrano, et al.
Journal of Neuropathology and Experimental Neurology
|
June 15, 2016
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
Jessica R Filon, Anthony J Intorcia, Lucia I Sue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2023
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium
Lavanya Jain, Maria Khrestian, Shane Formica, et al.
Plos One
|
April 23, 2020
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia
Thomas G Beach, Charles H Adler, Nan Zhang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
August 11, 2017
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
Stephen Salloway, Jose E Gamez, Upinder Singh, et al.
Brain : a Journal of Neurology
|
April 27, 2021
Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation
Clemens Neudorfer, Gavin J B Elias, Martin Jakobs, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2018
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation
Jeannie-Marie S Leoutsakos, Haijuan Yan, William S Anderson, et al.
JAMA Neurology
|
January 27, 2015
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density
Craig Curtis, Jose E Gamez, Upinder Singh, et al.
Page
of 33